| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |